IL1B and retinal degeneration: Overall, we demonstrate increased retinal expression of GSDMD in degeneration, and show that inhibition of GSDMD function in-vivo animal models of retinal degeneration and in-vitro reduces release of pro-inflammatory cytokine IL-1β, providing overall protection.